The discovery of general anesthesia 170 years ago was a medical miracle, enabling millions of patients to undergo invasive, life-saving surgeries without pain. 

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that the recently developed antidiabetic drug empagliflozin can treat and reverse the progression of heart failure in non-diabetic animal models. 

Scientists from Lancaster University have discovered that immune responses originally found to prevent fungal infections are also important in eliminating Trichinella spiralis, a round worm and the causative agent of Trichinosis.

Researchers at the Mucosal Immunology and Biology Research Center at MassGeneral Hospital for Children (MGHfC) have discovered novel genes and pathways related to early stages in the development of celiac disease and the ongoing inflammation and comorbidities associated with the condition. 

Victims of bullying in secondary school have dramatically increased chances of mental health problems and unemployment in later life.

New data published this week in the Journal of Allergy and Clinical Immunology: In Practice suggests that oral immunotherapy is safe for preschool-aged children with peanut allergies.

UBC researchers have determined the majority of men struggle when it comes to understanding the diagnosis and treatment of prostate cancer.

Researchers at the University of Toronto, The Hospital for Sick Children (SickKids) and the University of Calgary have ‘reverse engineered’ glioblastoma stem cells to uncover potential targets to treat the devastating form of brain cancer.

Researchers have provided the first evidence that mass drug administration (MDA) can grant community-level protection against Plasmodium falciparum (P. falciparum) malaria.

Oral cancer is known for its high mortality rate in developing countries, but an international team of scientists hope its latest discovery will change that.